HomeBody MapPeptidesCalculator
Catalog4 refs

Macimorelin

OtherResearch use only
Educational use only. Not medical advice. Verify all information with primary sources and a licensed clinician before use.
Half-life
2
Uses
0.5 mg
Typical
Body Map
Loading 3D model…
Circulation
Overview

Macimorelin (brand name Macrilen, also AEZS-130) is a peptidomimetic that mimics the hormone ghrelin. It binds the growth hormone secretagogue receptor (ghrelin receptor) on the anterior pituitary, provoking a burst of growth hormone into the blood. It is FDA approved as a diagnostic agent for adult growth hormone deficiency (AGHD), administered as a single oral dose followed by blood draws over 90 minutes to assess pituitary response.

Primary Uses
Diagnostic test for adult growth hormone deficiency (AGHD)
Assessment of pituitary growth hormone reserve
Protocol Reference
Dose
0.5 mg/kg oral single dose
Frequency
Single diagnostic test
Route
Oral solution, fasting
Evidence
FDA Approved
Research References· 1
FDA Approved Labeling \- Prescribed dose ↗
PubMedPMID 23533243#### Duration
Research Models
Human
Also in Other
Other
Abaloparatide
Osteoporosis treatment · Postmenopausal Osteoporosis
Other
ACE-031
Muscle Hypertrophy · Muscular Dystrophy
Other
ACTH (Cosyntropin)
Diagnostic tool to test adrenal gland function · Assess adrenal reserve
Other
Adrenocorticotropic hormone (ACTH)
adrenal insufficiency diagnosis · adrenal insufficiency treatment
Compare